Radiopharmaceutical Market

Market Overview for Radiopharmaceuticals for 2024 to 2034

Radiopharmaceuticals, in the limelight of heavy healthcare expenditures by affluent economies, is taking long strides in scientific innovations. FMI report suggests an overall global valuation of USD 6972.1 million in 2024.

Increased awareness of the benefits of radioisotope medications has slated this valuation to surpass USD 11635 million by 2034, growing at a CAGR of 3.40% for the forecast period of 2024 to 2034.

Attributes	Details
Radiopharmaceutical Market Value for 2024	USD 6972.1 million
Projected Market Value for 2034	USD 11635 million
Value-based CAGR from 2024 to 2034	3.40%

Radiopharmaceuticals Industry Analysis

• Pandemic-induced readiness in the healthcare and medicare sector, pushing public as well as private entities to invest hefty financial capital in the research and development of new medications, drugs, vaccines, etc.
• Prevalence of chronic diseases in developing and developed economies with well-established healthcare infrastructure, robust reimbursement policies, affluent per capita incomes, and increasing health consciousness.
• The industry-academia collaboration, in the past few decades, especially in the field of radio isotopic medication, bringing into the international marketplace novel formulations of medications, drugs, etc.
• The growing reliance on targeted therapies involving radionuclide-based therapies in cancer treatments to mitigate or control the spread of infection from one specific part of the body to another.
• Adoption of radiopharmaceuticals such as Radium-223, Lutetium-177, Samarium-153, and Actinium-225 to cure metastatic prostate cancer by medical professionals all over the world.
• Usual side-effects and allergic reactions faced by the patients after the dosage of radiopharmaceuticals to study a specific tissue or organ of the body, making patients hesitant to trust the efficacy of these treatments.
• Frequent visits to the hospital for radio chemotherapy due to its small dosages and prolonged treatment process are creating a sense of hesitancy in the minds of patients seeking this treatment which is affecting the adoption
• High costs, inefficient healthcare infrastructure, and long waiting periods for treatments, in underdeveloped parts of the world, are also impeding the market growth. Besides this, the lack of unskilled medical professionals and poor government healthcare policies also hinder market growth.

Consumption Analysis of Radiopharmaceuticals

• Cancer patients, across the world, form one of the largest consumer pools in the market for radiopharmaceuticals. This consumer group uses radionuclide-infused medications, drugs, vaccines, etc. to mitigate or stop the spread of tumors in the body.
• The sales of radiopharmaceuticals are also increasing among patients dealing with cardiovascular diseases such as myocardial perfusion imaging for coronary artery disease, etc. With more than half of the world population having these issues, this sale is very likely to surge in the coming future.
• Industry-wise, healthcare institutions, both public as well as private ones, procure radiopharmaceuticals for medical imaging services such as PET scans, SPECT scans, and other nuclear medicine procedures.
• Medical imaging centers also generate a significant demand for radiopharmaceuticals, such as Radium-223, Lutetium-177, Samarium-153, and Actinium-225, for various scans and tests.

Category-wise Insights

Cancer Therapies Involving Technetium-99 to Gain Popularity

Technetium-99, a metastable nuclear isomer of technetium-99, is one of the most commonly used isotopes in medical imaging. It is accounted to hold a share of 47.20% in the radiopharmaceutical market.

Attributes	Details
Radioisotope	Technetium-99
Market Share (2024)	47.20%

• The demand for Technetium-99, in the modern medicare sector, is touching the skies as it is usually used in single-photon emission computed tomography (SPECT) imaging. This enables medical practitioners to create detailed images of internal organs and tissues.
• Technietium-99-based radiopharmaceuticals can also be combined with other compounds and medications to detect tumors and infections in a wide range of medical conditions, including cardiovascular diseases, bone disorders, renal dysfunction, and cancer.

Oncology Treatments to Benefit from Radiopharmaceutical Medications

Attributes	Details
Application	Oncology
Market Share (2024)	51.40%

• According to World Cancer Research Fund International’s survey, 18.1 million people are diagnosed with cancer currently. This vast number has generated a huge demand for radiopharmaceuticals as it is one of the most important components in cancer diagnosis.
• Radiopharmaceuticals’ efficacy and effectiveness in cancer treatments and the trust shown by medical professionals in it for mitigating tumors, in medical imaging, and for regular monitoring is also augmenting its adoption worldwide.

Country-wise Analysis

Asian countries are set to become some of the lucrative markets for radiopharmaceuticals in the coming future. The growth rates for these countries have been jotted down below. Huge population, government policies, the prevalence of chronic diseases, such as cancer, and rising medical tourism are some of the main reasons for this growth.

Countries	CAGR (2024 to 2034)
India	5.40%
Malaysia	3.90%
Indonesia	3.70%
Thailand	3.20%
Spain	2.90%

Government Policies in India to Become a Boon for the Radiopharmaceuticals Industry

The Indian radiopharmaceutical industry is slated to grow at a healthy CAGR of 5.40% for the forecasted period.

• In the last few years, government policies in India regarding medical inclusion of the poor and middle class have changed the overall health infrastructure of the country. With the recent pandemic, this progress got a substantial boost.
• This medicare transformation has helped healthcare facilities across the country to easily adopt sophisticated methodologies involving the use of radiopharmaceuticals to treat cancers and other chronic diseases.

Malaysian Oncology to Benefit from Medical Tourism Activities

Malaysia is one of the most lucrative markets for radiopharmaceuticals. For the period of 2024 to 2034, the market is very likely to grow at a CAGR of 3.90%.

• The Malaysian market for radiopharmaceuticals is booming, thanks to its expanding medical tourism industry in the past few years. Each year, more than one million patients flock to the nation to take advantage of its advanced medical facilities.
• This cyclic migration of patients automatically generates substantial demand for radiopharmaceutical medications, drugs, vaccines, etc. Radiopharmaceuticals are also needed in medical imaging and regular monitoring of patients' overalls.

Breast and Cervical Cancer to Augment the Adoption of Radiopharmaceuticals in Indonesia

The Indonesian market for radiopharmaceuticals is set to grow at a sluggish CAGR of 3.70% through 2034.

• According to the National Center for Biotechnology Information, 3.80 million of the 270 million Indonesian population is dealing with cancer. This presents a great opportunity for pharmaceutical companies involved in the manufacturing of radiopharmaceuticals to cater to the medication requirements of healthcare facilities in Indonesia.
• Regular awareness policies by the Minister of Health of the Republic of Indonesia have also increased the adoption of radiopharmaceuticals as people are regularly conducting full-body checkups for early detection of cancer and other fatal diseases.

Cancer-treating Radiopharmaceuticals Gain Ground in Thailand

The Thai radiopharmaceutical market also has a promising future like the other Asian countries. It is very much likely to progress at 3.20% CAGR through 2034.

• The International Atomic Energy Association, under its new project, has started the clinical use and distribution of lutetium-177 (Lu-177)-DOTATATE - a radiopharmaceutical for treating neuroendocrine tumors, across various countries including Thailand.
• Distributions like this have made the adoption and implementation of radiopharmaceuticals in Thailand very feasible and affordable for the middle-class population, which in turn is amplifying the market growth.

Rising Incidences of Chronic Diseases to Augment Market Growth in Spain

The Spanish market for radiopharmaceuticals is accounted to grow at a CAGR of 2.90% for 2024 to 2034.

• Just like the majority of European and Western countries, Spain is currently dealing with the problem of rising incidences of chronic diseases such as cardiovascular diseases, cancer, obesity, etc.
• This growing prevalence in the Spanish general population has generated great demand in the international market for radiopharmaceuticals.

Competitive Landscape

The market for radiopharmaceuticals is still in its nascent stages with very few companies dominating the international marketplace. However, with medical advancements and the proliferation of these methodologies in the medical world, the requirement of radiopharmaceuticals will soon experience a drastic surge. This will provide excellent opportunities for new players to enter the market.

Some of the prominent companies in the market are Bayer AG, Bracco Imaging S.p.A., Cardinal Health, Inc., Eli Lilly and Company (Eli Lilly), Curium Pharma, Lantheus Holdings, Inc., Novartis AG, Nordion (Canada) Inc., etc. These companies provide radiopharmaceuticals to healthcare facilities such as hospitals, ambulatory surgical centers, clinics, specialty hospitals, etc.

Innovation and keeping up with the latest medical technology are the key components in this market. This is the reason why, these companies are found to be investing millions of dollars in the development of novel radiopharmaceuticals with better efficiency.

Besides this, collaborative efforts with government bodies are also being carried out to make the offering more affordable, feasible, and easily available, especially in developing and underdeveloped parts of the world.

Recent Developments

• In February 2024, Bayer solidified a partnership with PanTera, obtaining actinium-225 for pioneering radiopharmaceuticals. This collaboration marked PanTera's debut with a major pharmaceutical firm, commencing clinical trial provision in the latter half of the year.
• In March 2024, Ariceum Therapeutics inaugurated its Berlin-based radiopharmaceutical laboratory, enabling internal R&D for upcoming pipeline candidates
• In March 2024, Ratio Therapeutics Inc. revealed an extended manufacturing deal with PharmaLogic, a renowned CDMO for radiopharmaceuticals. The partnership aimed to expedite the production and launch of Ratio's cutting-edge radiotherapies, particularly its FAP-targeted candidate.
• In March 2024, Telix Pharmaceuticals acquired ARTMS Inc. for up to USD 82 million, expanding its radiopharmaceutical capabilities. The deal provided access to advanced isotope production technology, a manufacturing facility, and a reserve of ultrapure rare metals, bolstering Telix's presence in the industry.

Key Companies

• Bayer AG
• Bracco Imaging S.p.A.
• Cardinal Health, Inc.
• Eli Lilly and Company (Eli Lilly)
• Curium Pharma
• Lantheus Holdings, Inc.
• Novartis AG
• Nordion (Canada) Inc.
• Jubilant Radiopharma

Key Coverage in the Radiopharmaceutical Market

• Growth of the Radiopharmaceutical Market
• demand for radiopharmaceuticals in Developing Countries
• North America Radiopharmaceuticals Market
• Industrial Analysis of Nuclear Medicine Market
• Radiopharmaceuticals Demand Analysis

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Radioisotope Type
  • 5.1. Technetium-99
  • 5.2. Fluorine-18
  • 5.3. Iodine-131
  • 5.4. Leutetium-177
  • 5.5. Yttrium-90
  • 5.6. Gallium-68
  • 5.7. Gallium-67
  • 5.8. Rubidium-82
  • 5.9. Iodine-123
  • 5.10. Iodine-125
  • 5.11. Indium-111
  • 5.12. Others
• 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
  • 6.1. Oncology
  • 6.2. Cardiology
  • 6.3. Gastroenterology
  • 6.4. Neuroendocrinology
  • 6.5. Neurology
  • 6.6. Nephrology
  • 6.7. Others
• 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Source
  • 7.1. Cyclotrons
  • 7.2. Nuclear Reactors
• 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
  • 8.1. Hospitals
  • 8.2. Diagnostic Imaging Centers
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Cancer Research Institute
• 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 9.1. North America
  • 9.2. Latin America
  • 9.3. Western Europe
  • 9.4. Eastern Europe
  • 9.5. South Asia and Pacific
  • 9.6. East Asia
  • 9.7. Middle East and Africa
• 10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 17. Key Countries Market Analysis
• 18. Market Structure Analysis
• 19. Competition Analysis
  • 19.1. Siemens AG
  • 19.2. Positron Corporation
  • 19.3. Novartis (Advanced Accelerator Applications)
  • 19.4. Curium
  • 19.5. GE Healthcare
  • 19.6. Lantheus Holdings Inc.
  • 19.7. Sotera Health LLC (Nordion Inc.)
  • 19.8. Bayer AG
  • 19.9. Eckert & Ziegler
• 20. Assumptions & Acronyms Used
• 21. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Volume (Tons) Forecast by Region, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Radioisotope Type, 2019 to 2034

Table 4: Global Market Volume (Tons) Forecast by Radioisotope Type, 2019 to 2034

Table 5: Global Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 6: Global Market Volume (Tons) Forecast by Application, 2019 to 2034

Table 7: Global Market Value (US$ Million) Forecast by Source, 2019 to 2034

Table 8: Global Market Volume (Tons) Forecast by Source, 2019 to 2034

Table 9: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 10: Global Market Volume (Tons) Forecast by End User, 2019 to 2034

Table 11: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 12: North America Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 13: North America Market Value (US$ Million) Forecast by Radioisotope Type, 2019 to 2034

Table 14: North America Market Volume (Tons) Forecast by Radioisotope Type, 2019 to 2034

Table 15: North America Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 16: North America Market Volume (Tons) Forecast by Application, 2019 to 2034

Table 17: North America Market Value (US$ Million) Forecast by Source, 2019 to 2034

Table 18: North America Market Volume (Tons) Forecast by Source, 2019 to 2034

Table 19: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 20: North America Market Volume (Tons) Forecast by End User, 2019 to 2034

Table 21: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 22: Latin America Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 23: Latin America Market Value (US$ Million) Forecast by Radioisotope Type, 2019 to 2034

Table 24: Latin America Market Volume (Tons) Forecast by Radioisotope Type, 2019 to 2034

Table 25: Latin America Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 26: Latin America Market Volume (Tons) Forecast by Application, 2019 to 2034

Table 27: Latin America Market Value (US$ Million) Forecast by Source, 2019 to 2034

Table 28: Latin America Market Volume (Tons) Forecast by Source, 2019 to 2034

Table 29: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 30: Latin America Market Volume (Tons) Forecast by End User, 2019 to 2034

Table 31: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 32: Western Europe Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 33: Western Europe Market Value (US$ Million) Forecast by Radioisotope Type, 2019 to 2034

Table 34: Western Europe Market Volume (Tons) Forecast by Radioisotope Type, 2019 to 2034

Table 35: Western Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 36: Western Europe Market Volume (Tons) Forecast by Application, 2019 to 2034

Table 37: Western Europe Market Value (US$ Million) Forecast by Source, 2019 to 2034

Table 38: Western Europe Market Volume (Tons) Forecast by Source, 2019 to 2034

Table 39: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 40: Western Europe Market Volume (Tons) Forecast by End User, 2019 to 2034

Table 41: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 42: Eastern Europe Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 43: Eastern Europe Market Value (US$ Million) Forecast by Radioisotope Type, 2019 to 2034

Table 44: Eastern Europe Market Volume (Tons) Forecast by Radioisotope Type, 2019 to 2034

Table 45: Eastern Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 46: Eastern Europe Market Volume (Tons) Forecast by Application, 2019 to 2034

Table 47: Eastern Europe Market Value (US$ Million) Forecast by Source, 2019 to 2034

Table 48: Eastern Europe Market Volume (Tons) Forecast by Source, 2019 to 2034

Table 49: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 50: Eastern Europe Market Volume (Tons) Forecast by End User, 2019 to 2034

Table 51: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 52: South Asia and Pacific Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 53: South Asia and Pacific Market Value (US$ Million) Forecast by Radioisotope Type, 2019 to 2034

Table 54: South Asia and Pacific Market Volume (Tons) Forecast by Radioisotope Type, 2019 to 2034

Table 55: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 56: South Asia and Pacific Market Volume (Tons) Forecast by Application, 2019 to 2034

Table 57: South Asia and Pacific Market Value (US$ Million) Forecast by Source, 2019 to 2034

Table 58: South Asia and Pacific Market Volume (Tons) Forecast by Source, 2019 to 2034

Table 59: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 60: South Asia and Pacific Market Volume (Tons) Forecast by End User, 2019 to 2034

Table 61: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 62: East Asia Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 63: East Asia Market Value (US$ Million) Forecast by Radioisotope Type, 2019 to 2034

Table 64: East Asia Market Volume (Tons) Forecast by Radioisotope Type, 2019 to 2034

Table 65: East Asia Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 66: East Asia Market Volume (Tons) Forecast by Application, 2019 to 2034

Table 67: East Asia Market Value (US$ Million) Forecast by Source, 2019 to 2034

Table 68: East Asia Market Volume (Tons) Forecast by Source, 2019 to 2034

Table 69: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 70: East Asia Market Volume (Tons) Forecast by End User, 2019 to 2034

Table 71: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 72: Middle East and Africa Market Volume (Tons) Forecast by Country, 2019 to 2034

Table 73: Middle East and Africa Market Value (US$ Million) Forecast by Radioisotope Type, 2019 to 2034

Table 74: Middle East and Africa Market Volume (Tons) Forecast by Radioisotope Type, 2019 to 2034

Table 75: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 76: Middle East and Africa Market Volume (Tons) Forecast by Application, 2019 to 2034

Table 77: Middle East and Africa Market Value (US$ Million) Forecast by Source, 2019 to 2034

Table 78: Middle East and Africa Market Volume (Tons) Forecast by Source, 2019 to 2034

Table 79: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 80: Middle East and Africa Market Volume (Tons) Forecast by End User, 2019 to 2034

List of Figures

Figure 1: Global Market Value (US$ Million) by Radioisotope Type, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by Application, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by Source, 2024 to 2034

Figure 4: Global Market Value (US$ Million) by End User, 2024 to 2034

Figure 5: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 6: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 7: Global Market Volume (Tons) Analysis by Region, 2019 to 2034

Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 10: Global Market Value (US$ Million) Analysis by Radioisotope Type, 2019 to 2034

Figure 11: Global Market Volume (Tons) Analysis by Radioisotope Type, 2019 to 2034

Figure 12: Global Market Value Share (%) and BPS Analysis by Radioisotope Type, 2024 to 2034

Figure 13: Global Market Y-o-Y Growth (%) Projections by Radioisotope Type, 2024 to 2034

Figure 14: Global Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 15: Global Market Volume (Tons) Analysis by Application, 2019 to 2034

Figure 16: Global Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 17: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 18: Global Market Value (US$ Million) Analysis by Source, 2019 to 2034

Figure 19: Global Market Volume (Tons) Analysis by Source, 2019 to 2034

Figure 20: Global Market Value Share (%) and BPS Analysis by Source, 2024 to 2034

Figure 21: Global Market Y-o-Y Growth (%) Projections by Source, 2024 to 2034

Figure 22: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 23: Global Market Volume (Tons) Analysis by End User, 2019 to 2034

Figure 24: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 25: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 26: Global Market Attractiveness by Radioisotope Type, 2024 to 2034

Figure 27: Global Market Attractiveness by Application, 2024 to 2034

Figure 28: Global Market Attractiveness by Source, 2024 to 2034

Figure 29: Global Market Attractiveness by End User, 2024 to 2034

Figure 30: Global Market Attractiveness by Region, 2024 to 2034

Figure 31: North America Market Value (US$ Million) by Radioisotope Type, 2024 to 2034

Figure 32: North America Market Value (US$ Million) by Application, 2024 to 2034

Figure 33: North America Market Value (US$ Million) by Source, 2024 to 2034

Figure 34: North America Market Value (US$ Million) by End User, 2024 to 2034

Figure 35: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 36: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 37: North America Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 40: North America Market Value (US$ Million) Analysis by Radioisotope Type, 2019 to 2034

Figure 41: North America Market Volume (Tons) Analysis by Radioisotope Type, 2019 to 2034

Figure 42: North America Market Value Share (%) and BPS Analysis by Radioisotope Type, 2024 to 2034

Figure 43: North America Market Y-o-Y Growth (%) Projections by Radioisotope Type, 2024 to 2034

Figure 44: North America Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 45: North America Market Volume (Tons) Analysis by Application, 2019 to 2034

Figure 46: North America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 47: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 48: North America Market Value (US$ Million) Analysis by Source, 2019 to 2034

Figure 49: North America Market Volume (Tons) Analysis by Source, 2019 to 2034

Figure 50: North America Market Value Share (%) and BPS Analysis by Source, 2024 to 2034

Figure 51: North America Market Y-o-Y Growth (%) Projections by Source, 2024 to 2034

Figure 52: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 53: North America Market Volume (Tons) Analysis by End User, 2019 to 2034

Figure 54: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 55: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 56: North America Market Attractiveness by Radioisotope Type, 2024 to 2034

Figure 57: North America Market Attractiveness by Application, 2024 to 2034

Figure 58: North America Market Attractiveness by Source, 2024 to 2034

Figure 59: North America Market Attractiveness by End User, 2024 to 2034

Figure 60: North America Market Attractiveness by Country, 2024 to 2034

Figure 61: Latin America Market Value (US$ Million) by Radioisotope Type, 2024 to 2034

Figure 62: Latin America Market Value (US$ Million) by Application, 2024 to 2034

Figure 63: Latin America Market Value (US$ Million) by Source, 2024 to 2034

Figure 64: Latin America Market Value (US$ Million) by End User, 2024 to 2034

Figure 65: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 66: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 67: Latin America Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 70: Latin America Market Value (US$ Million) Analysis by Radioisotope Type, 2019 to 2034

Figure 71: Latin America Market Volume (Tons) Analysis by Radioisotope Type, 2019 to 2034

Figure 72: Latin America Market Value Share (%) and BPS Analysis by Radioisotope Type, 2024 to 2034

Figure 73: Latin America Market Y-o-Y Growth (%) Projections by Radioisotope Type, 2024 to 2034

Figure 74: Latin America Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 75: Latin America Market Volume (Tons) Analysis by Application, 2019 to 2034

Figure 76: Latin America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 77: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 78: Latin America Market Value (US$ Million) Analysis by Source, 2019 to 2034

Figure 79: Latin America Market Volume (Tons) Analysis by Source, 2019 to 2034

Figure 80: Latin America Market Value Share (%) and BPS Analysis by Source, 2024 to 2034

Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Source, 2024 to 2034

Figure 82: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 83: Latin America Market Volume (Tons) Analysis by End User, 2019 to 2034

Figure 84: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 85: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 86: Latin America Market Attractiveness by Radioisotope Type, 2024 to 2034

Figure 87: Latin America Market Attractiveness by Application, 2024 to 2034

Figure 88: Latin America Market Attractiveness by Source, 2024 to 2034

Figure 89: Latin America Market Attractiveness by End User, 2024 to 2034

Figure 90: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 91: Western Europe Market Value (US$ Million) by Radioisotope Type, 2024 to 2034

Figure 92: Western Europe Market Value (US$ Million) by Application, 2024 to 2034

Figure 93: Western Europe Market Value (US$ Million) by Source, 2024 to 2034

Figure 94: Western Europe Market Value (US$ Million) by End User, 2024 to 2034

Figure 95: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 96: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 97: Western Europe Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 98: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 99: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 100: Western Europe Market Value (US$ Million) Analysis by Radioisotope Type, 2019 to 2034

Figure 101: Western Europe Market Volume (Tons) Analysis by Radioisotope Type, 2019 to 2034

Figure 102: Western Europe Market Value Share (%) and BPS Analysis by Radioisotope Type, 2024 to 2034

Figure 103: Western Europe Market Y-o-Y Growth (%) Projections by Radioisotope Type, 2024 to 2034

Figure 104: Western Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 105: Western Europe Market Volume (Tons) Analysis by Application, 2019 to 2034

Figure 106: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 107: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 108: Western Europe Market Value (US$ Million) Analysis by Source, 2019 to 2034

Figure 109: Western Europe Market Volume (Tons) Analysis by Source, 2019 to 2034

Figure 110: Western Europe Market Value Share (%) and BPS Analysis by Source, 2024 to 2034

Figure 111: Western Europe Market Y-o-Y Growth (%) Projections by Source, 2024 to 2034

Figure 112: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 113: Western Europe Market Volume (Tons) Analysis by End User, 2019 to 2034

Figure 114: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 115: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 116: Western Europe Market Attractiveness by Radioisotope Type, 2024 to 2034

Figure 117: Western Europe Market Attractiveness by Application, 2024 to 2034

Figure 118: Western Europe Market Attractiveness by Source, 2024 to 2034

Figure 119: Western Europe Market Attractiveness by End User, 2024 to 2034

Figure 120: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 121: Eastern Europe Market Value (US$ Million) by Radioisotope Type, 2024 to 2034

Figure 122: Eastern Europe Market Value (US$ Million) by Application, 2024 to 2034

Figure 123: Eastern Europe Market Value (US$ Million) by Source, 2024 to 2034

Figure 124: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034

Figure 125: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 126: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 127: Eastern Europe Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 128: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 129: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 130: Eastern Europe Market Value (US$ Million) Analysis by Radioisotope Type, 2019 to 2034

Figure 131: Eastern Europe Market Volume (Tons) Analysis by Radioisotope Type, 2019 to 2034

Figure 132: Eastern Europe Market Value Share (%) and BPS Analysis by Radioisotope Type, 2024 to 2034

Figure 133: Eastern Europe Market Y-o-Y Growth (%) Projections by Radioisotope Type, 2024 to 2034

Figure 134: Eastern Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 135: Eastern Europe Market Volume (Tons) Analysis by Application, 2019 to 2034

Figure 136: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 137: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 138: Eastern Europe Market Value (US$ Million) Analysis by Source, 2019 to 2034

Figure 139: Eastern Europe Market Volume (Tons) Analysis by Source, 2019 to 2034

Figure 140: Eastern Europe Market Value Share (%) and BPS Analysis by Source, 2024 to 2034

Figure 141: Eastern Europe Market Y-o-Y Growth (%) Projections by Source, 2024 to 2034

Figure 142: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 143: Eastern Europe Market Volume (Tons) Analysis by End User, 2019 to 2034

Figure 144: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 145: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 146: Eastern Europe Market Attractiveness by Radioisotope Type, 2024 to 2034

Figure 147: Eastern Europe Market Attractiveness by Application, 2024 to 2034

Figure 148: Eastern Europe Market Attractiveness by Source, 2024 to 2034

Figure 149: Eastern Europe Market Attractiveness by End User, 2024 to 2034

Figure 150: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 151: South Asia and Pacific Market Value (US$ Million) by Radioisotope Type, 2024 to 2034

Figure 152: South Asia and Pacific Market Value (US$ Million) by Application, 2024 to 2034

Figure 153: South Asia and Pacific Market Value (US$ Million) by Source, 2024 to 2034

Figure 154: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034

Figure 155: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 156: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 157: South Asia and Pacific Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 158: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 159: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 160: South Asia and Pacific Market Value (US$ Million) Analysis by Radioisotope Type, 2019 to 2034

Figure 161: South Asia and Pacific Market Volume (Tons) Analysis by Radioisotope Type, 2019 to 2034

Figure 162: South Asia and Pacific Market Value Share (%) and BPS Analysis by Radioisotope Type, 2024 to 2034

Figure 163: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Radioisotope Type, 2024 to 2034

Figure 164: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 165: South Asia and Pacific Market Volume (Tons) Analysis by Application, 2019 to 2034

Figure 166: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 167: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 168: South Asia and Pacific Market Value (US$ Million) Analysis by Source, 2019 to 2034

Figure 169: South Asia and Pacific Market Volume (Tons) Analysis by Source, 2019 to 2034

Figure 170: South Asia and Pacific Market Value Share (%) and BPS Analysis by Source, 2024 to 2034

Figure 171: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Source, 2024 to 2034

Figure 172: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 173: South Asia and Pacific Market Volume (Tons) Analysis by End User, 2019 to 2034

Figure 174: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 175: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 176: South Asia and Pacific Market Attractiveness by Radioisotope Type, 2024 to 2034

Figure 177: South Asia and Pacific Market Attractiveness by Application, 2024 to 2034

Figure 178: South Asia and Pacific Market Attractiveness by Source, 2024 to 2034

Figure 179: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034

Figure 180: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 181: East Asia Market Value (US$ Million) by Radioisotope Type, 2024 to 2034

Figure 182: East Asia Market Value (US$ Million) by Application, 2024 to 2034

Figure 183: East Asia Market Value (US$ Million) by Source, 2024 to 2034

Figure 184: East Asia Market Value (US$ Million) by End User, 2024 to 2034

Figure 185: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 186: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 187: East Asia Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 188: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 189: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 190: East Asia Market Value (US$ Million) Analysis by Radioisotope Type, 2019 to 2034

Figure 191: East Asia Market Volume (Tons) Analysis by Radioisotope Type, 2019 to 2034

Figure 192: East Asia Market Value Share (%) and BPS Analysis by Radioisotope Type, 2024 to 2034

Figure 193: East Asia Market Y-o-Y Growth (%) Projections by Radioisotope Type, 2024 to 2034

Figure 194: East Asia Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 195: East Asia Market Volume (Tons) Analysis by Application, 2019 to 2034

Figure 196: East Asia Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 197: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 198: East Asia Market Value (US$ Million) Analysis by Source, 2019 to 2034

Figure 199: East Asia Market Volume (Tons) Analysis by Source, 2019 to 2034

Figure 200: East Asia Market Value Share (%) and BPS Analysis by Source, 2024 to 2034

Figure 201: East Asia Market Y-o-Y Growth (%) Projections by Source, 2024 to 2034

Figure 202: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 203: East Asia Market Volume (Tons) Analysis by End User, 2019 to 2034

Figure 204: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 205: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 206: East Asia Market Attractiveness by Radioisotope Type, 2024 to 2034

Figure 207: East Asia Market Attractiveness by Application, 2024 to 2034

Figure 208: East Asia Market Attractiveness by Source, 2024 to 2034

Figure 209: East Asia Market Attractiveness by End User, 2024 to 2034

Figure 210: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 211: Middle East and Africa Market Value (US$ Million) by Radioisotope Type, 2024 to 2034

Figure 212: Middle East and Africa Market Value (US$ Million) by Application, 2024 to 2034

Figure 213: Middle East and Africa Market Value (US$ Million) by Source, 2024 to 2034

Figure 214: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034

Figure 215: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 216: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 217: Middle East and Africa Market Volume (Tons) Analysis by Country, 2019 to 2034

Figure 218: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 219: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 220: Middle East and Africa Market Value (US$ Million) Analysis by Radioisotope Type, 2019 to 2034

Figure 221: Middle East and Africa Market Volume (Tons) Analysis by Radioisotope Type, 2019 to 2034

Figure 222: Middle East and Africa Market Value Share (%) and BPS Analysis by Radioisotope Type, 2024 to 2034

Figure 223: Middle East and Africa Market Y-o-Y Growth (%) Projections by Radioisotope Type, 2024 to 2034

Figure 224: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 225: Middle East and Africa Market Volume (Tons) Analysis by Application, 2019 to 2034

Figure 226: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 227: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 228: Middle East and Africa Market Value (US$ Million) Analysis by Source, 2019 to 2034

Figure 229: Middle East and Africa Market Volume (Tons) Analysis by Source, 2019 to 2034

Figure 230: Middle East and Africa Market Value Share (%) and BPS Analysis by Source, 2024 to 2034

Figure 231: Middle East and Africa Market Y-o-Y Growth (%) Projections by Source, 2024 to 2034

Figure 232: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 233: Middle East and Africa Market Volume (Tons) Analysis by End User, 2019 to 2034

Figure 234: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 235: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 236: Middle East and Africa Market Attractiveness by Radioisotope Type, 2024 to 2034

Figure 237: Middle East and Africa Market Attractiveness by Application, 2024 to 2034

Figure 238: Middle East and Africa Market Attractiveness by Source, 2024 to 2034

Figure 239: Middle East and Africa Market Attractiveness by End User, 2024 to 2034

Figure 240: Middle East and Africa Market Attractiveness by Country, 2024 to 2034